For more than two decades, Edwin Rubis has done all he can think of to demonstrate that he is a changed man. He tells High Times that drug and alcohol addiction pulled him into the illicit cannabis business, which he only entered to settle debts. Federal agents argue otherwise, convicting the long-time Texas native of… Keep Reading
Part of what makes competing in today’s legal landscape so difficult is that it takes far more than just a quality product to attract consumers. While back in the medical days, many cultivators weren’t even branding their stuff, let alone designing flashy packaging, today, it’s essential for any producer who wants to see their consumer… Keep Reading
It’s no secret that if you’re working in the cannabis industry, you need to be on top of everything coming your way. One woman who’s dominating her role in the industry is Vice President of Strategy and Product at Viola Brands, Stephanie Arakel. Arakel’s journey into cannabis grew organically starting with her culinary college career,… Keep Reading
The more cannabis becomes accepted in the U.S., the more frustrating it becomes that cannabis researchers are barred by Schedule I status and cannot freely research, as well as that communities of color remain more at-risk for incarceration. The new PBS and NOVA documentary The Cannabis Question tackles both problems in one, succinct film. The… Keep Reading
I’m neither the first nor the last person to tell you that the fifth season of Rick and Morty—which concluded with an hour-long special episode last Sunday—is the most disappointing one to date. It has also produced some of the most controversial episodes in a catalog that also includes “Claw and Hoarder.” “Rickdependence Spray,” a… Keep Reading
The fact that comedian Jon Gabrus is thriving should not come as a surprise to anyone. The host and creator of the wildly popular Headgum podcast, High and Mighty, moved the show to his home studio during quarantine, and it’s where he’s been recording for over the past year. In fact, his first podcast has… Keep Reading
Oxford-based startup Beckley Psytech in the United Kingdom announced August 15 that it raised $80 million to ramp up clinical trials and research using a pharmaceutical formulation of 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), a powerful compound produced endogenously by Sonoran Desert toad venom, to treat depression. The Series B financing was initially set at $50 million—but was upgraded… Keep Reading
Number 13! Not going to lie, I never expected my attention (or anyone else’s) to last so long that I’d ever be at the 13th edition of my Quarantine Cop List, so pardon me for a moment while I relish in the irony of the old adage that stoners don’t get anything done… Apparently they… Keep Reading
This elegy for Bob Marley reminds us that 40 years after his death, we still mourn the legend. Read More Author: High Times / High Times Keep Reading
A journal excerpt by Eric Bogosian that reveals the shocking truth about the Love Generation. Read More Author: High Times / High Times Keep Reading
